Inhibitory effect of receptor for advanced glycation end product‑specific small interfering RNAs on the development of hepatic fibrosis in primary rat hepatic stellate cells

Xia,Jin‑Rong; Chen,Ting‑Ting; Li,Wei‑Dong; Lu,Feng‑Lin; Liu,Juan; Cai,Xiao‑Gang; Lu,Qin; Yang,Cui-Ping

doi:10.3892/mmr.2015.3342

Inhibitory effect of receptor for advanced glycation end product‑specific small interfering RNAs on the development of hepatic fibrosis in primary rat hepatic stellate cells

Authors:
- Jin‑Rong Xia
- Ting‑Ting Chen
- Wei‑Dong Li
- Feng‑Lin Lu
- Juan Liu
- Xiao‑Gang Cai
- Qin Lu
- Cui-Ping Yang
View Affiliations

Affiliations: Department of Gastroenterology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, P.R. China, Department of Gastroenterology, Binzhou People's Hospital, Binzhou, Shandong 256610, P.R. China, Department of Gastroenterology, Shanghai First People's Hospital, Shanghai 200080, P.R. China
Published online on: February 12, 2015 https://doi.org/10.3892/mmr.2015.3342
Pages: 569-574

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Specific small interfering RNAs (siRNAs) targeting receptor for advanced glycation end products (RAGE) inhibit the expression of RAGE, α‑smooth muscle actin and type I collagen in the T6 hepatic stellate cells (HSCs), indicating that RAGE is important for the activation of HSCs and the expression of collagen. The present study aimed to investigate the effect of specific siRNAs targeting RAGE on the development of hepatic fibrosis (HF), using primary rat HSCs, which were isolated and cultured in vitro. The expression vectors for specific siRNAs targeting RAGE were constructed and transfected into primary rat HSCs. Untreated and nonspecific siRNA‑transfected primary rat HSCs served as controls. The expression levels of RAGE, interleukin‑6 (IL‑6), tumor necrosis factor‑α (TNF‑α), transforming growth factor‑β1 (TGF‑β1), connective tissue growth factor (CTGF), laminin (LN), hyaluronic acid (HA) and N‑terminal procollagen III propeptide (PIIINP) in primary HSCs were detected by reverse transcription quantitative polymerase chain reaction and western blotting. The mRNA and 42 kD protein expression of RAGE in the pAKD‑GR126‑transfected primary HSCs were significantly downregulated compared with those in the untreated and the pAKD‑negative control (NC)‑transfected controls. The mRNA and protein expression levels of IL‑6, TNF‑α, TGF‑β1, CTGF, LN, HA and PIIINP in the pAKD‑GR126‑transfected primary HSCs were also markedly downregulated compared with those in the untreated and pAKD‑NC‑transfected controls. Therefore, RAGE‑specific siRNAs inhibited the expression of RAGE in primary rat HSCs and inhibited the development of HF.

View Figures

View References

1	Bierhaus A, Humpert PM, Morcos M, et al: Nawroth, Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berl). 83:876–886. 2005. View Article : Google Scholar
2	Hegab Z, Gibbons S, Neyses L and Mamas MA: Role of advanced glycation end products in cardiovascular disease. World J Cardiol. 4:90–102. 2012. View Article : Google Scholar : PubMed/NCBI
3	Yan SD, Bierhaus A, Nawroth PP and Stern DM: RAGE and Alzheimer’s disease: a progression factor for amyloid-beta-induced cellular perturbation? J Alzheimers Dis. 16:833–843. 2009.
4	Oleniuc M, Secara I, Onofriescu M, Hogas S, et al: Consequences of advanced glycation end products accumulation in chronic kidney disease and clinical usefulness of their assessment using a non-invasive technique-skin autofluorescence. Maedica (Buchar). 6:298–307. 2011.
5	Barlovic DP, Soro-Paavonen A and Jandeleit-Dahm KA: RAGE biology, atherosclerosis and diabetes. Clin Sci (Lond). 211:43–55. 2011. View Article : Google Scholar
6	Schwenger V, Morath C, Salava A, et al: Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products. J Am Soc Nephrol. 17:199–207. 2006. View Article : Google Scholar
7	Vlassara H, Striker LJ, Teichberg S, et al: Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proc Natl Acad Sci USA. 91:11704–11708. 1994. View Article : Google Scholar : PubMed/NCBI
8	Fehrenbach H, Weiskirchen R, Kasper M and Gressner AM: Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts. Hepatology. 34:943–952. 2001. View Article : Google Scholar : PubMed/NCBI
9	Guimarães EL, Empsen C, Geerts A and van Grunsven LA: Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells. J Hepatol. 52:389–397. 2010. View Article : Google Scholar : PubMed/NCBI
10	Iwamoto K, Kanno K, Hyogo H, et al: Advanced glycation end products enhance the proliferation and activation of hepatic stellate cells. J Gastroenterol. 43:298–304. 2008. View Article : Google Scholar : PubMed/NCBI
11	Xia JR, Liu NF and Zhu NX: Specific siRNA targeting the receptor for advanced glycation end products inhibits experimental hepatic fibrosis in rats. Int J Mol Sci. 9:638–661. 2008. View Article : Google Scholar
12	Lohwasser C, Neureiter D, Popov Y, Bauer M and Schuppan D: Role of the receptor for advanced glycation end products in hepatic fibrosis. World J Gastroenterol. 15:5789–5798. 2009. View Article : Google Scholar : PubMed/NCBI
13	Friedman SL and Roll FJ: Isolation and culture of hepatic lipocytes, Kuper cells, and sinusoidal endothelial cells by density gradient centreifugation with Stractan. Anal Biochem. 161:207–218. 1987. View Article : Google Scholar : PubMed/NCBI
14	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PRC and the 2 (− Delta Delta C(T) method. Methods. 25:402–408. 2001. View Article : Google Scholar
15	Xie X, Zhao R and Shen GX: Impact of cyanidin-3-glucoside on glycated LDL-induced NADPH oxidase activation, mitochondrial dysfunction and cell viability in cultured vascular endothelial cells. Int J Mol Sci. 13:15867–15880. 2012. View Article : Google Scholar
16	Sangle GV, Zhao R, Mizuno TM and Shen GX: Involvement of RAGE, NADPH oxidase, and Ras/Raf-1 pathway in glycated LDL-induced expression of heat shock factor-1 and plasminogen activator inhibitor-1 in vascular endothelial cells. Endocrinology. 151:4455–4466. 2010. View Article : Google Scholar : PubMed/NCBI
17	Willems S, Verleden SE, Vanaudenaerde BM, et al: Multiplex protein profiling of bronchoalveolar lavage in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis. Ann Thorac Med. 8:38–45. 2013. View Article : Google Scholar : PubMed/NCBI
18	Cheng A, Dong Y, Zhu F, et al: AGE-LDL activates Toll like receptor 4 pathway and promotes inflammatory cytokines production in renal tubular epithelial cells. Int J Biol Sci. 9:94–107. 2013. View Article : Google Scholar : PubMed/NCBI
19	Honsawek S, Vejchapipat P, Payungporn S, et al: Soluble receptor for advanced glycation end products and liver stiffness in postoperative biliary atresia. Clin Biochem. 46:214–218. 2013. View Article : Google Scholar
20	Goodwin M, Herath C, Jia Z, et al: Advanced glycation end products augment experimental hepatic fibrosis. J Gastroenterol Hepatol. 28:369–376. 2013. View Article : Google Scholar
21	Sebeková K, Kupcová V, Schinzel R and Heidland A: Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis-amelioration by liver transplantation. J Hepatol. 36:66–71. 2002. View Article : Google Scholar
22	Ahmed N, Lüthen R, Häussinger D, et al: Increased protein glycation in cirrhosis and therapeutic strategies to prevent it. Ann N Y Acad Sci. 1043:718–724. 2005. View Article : Google Scholar : PubMed/NCBI
23	Yagmur E, Tacke F, Weiss C, et al: Elevation of Nepsilon-(carboxymethyl) lysine-modified advanced glycation end products in chronic liver disease is an indicator of liver cirrhosis. Clin Biochem. 39:39–45. 2006. View Article : Google Scholar
24	Oldfield MD, Bach LA, Forbes JM, et al: Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest. 108:1853–1863. 2001. View Article : Google Scholar : PubMed/NCBI
25	Lin J, Tang Y, Kang Q, Feng Y and Chen A: Curcumin inhibits gene expression of receptor for advanced glycation end-products (RAGE) in hepatic stellate cells in vitro by elevating PPARγ activity and attenuating oxidative stress. Br J Pharmacol. 166:2212–2227. 2012. View Article : Google Scholar : PubMed/NCBI
26	Reynaert H, Thompson MG, Thomas T and Geerts A: Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension. Gut. 50:571–581. 2002. View Article : Google Scholar : PubMed/NCBI
27	Shi GF and Li Q: Effects of oxymatrine on experimental hepatic fibrosis and its mechanism in vivo. World J Gastroenterol. 11:268–271. 2005. View Article : Google Scholar : PubMed/NCBI
28	Reeves HL and Friedman SL: Activation of hepatic stellate ceils-a key issue in liver fibrosis. Front Biosci. 7:d808–d826. 2002. View Article : Google Scholar : PubMed/NCBI
29	Campbell JS, Hughes SD, Gilbertson DG, et al: Pletelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. Proc Natl Acad Sci USA. 102:3389–3394. 2005. View Article : Google Scholar
30	Sakaida I, Hironaka K, Kimura T, et al: Herbal medicine sho-saiko-to(TJ-9) increases expression matrix metalloproteinases (MMPs) with reduced expression of tissue inhibitor of metalloproteinases (TIMPs) in rat stellate cell. Life Sci. 74:2251–2263. 2004. View Article : Google Scholar : PubMed/NCBI
31	Iredale JP: Hepatic stellate cell behavior during resolution of liver injury. Semin Liver Dis. 21:427–436. 2001. View Article : Google Scholar : PubMed/NCBI
32	Benyon RC and Arthur MJ: Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis. 21:373–384. 2001. View Article : Google Scholar : PubMed/NCBI
33	Borkham-Kamphorst E, Herrmann J, Stoll D, et al: Dominent-negative solute PDGF-beta receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis. Lab Invest. 84:766–777. 2004. View Article : Google Scholar : PubMed/NCBI
34	Novosyadlyy R, Tron K, Dudas J, Ramadori G and Scharf JG: Expression and regulation of the insulin-like growth factor axis components in rat liver myofibroblasts. J Cell Physiol. 199:388–398. 2004. View Article : Google Scholar : PubMed/NCBI
35	Simeonova PP, Gallucci RM, Hulderman T, et al: The role of tumor necrosis factor-alpha in liver toxicity, inflammation, and fibrosis induced by carbon tetrachloride. Toxicol Appl Pharmacol. 177:112–120. 2001. View Article : Google Scholar : PubMed/NCBI
36	da Silva FM, Guimarães EL, Grivicich I, et al: Hepatic stellate cell activation in vitro: cell cycle arrest at G2/M and modification of cell motility. J Cell Biochem. 90:387–396. 2003. View Article : Google Scholar : PubMed/NCBI
37	Huang G and Brigstock DR: Integrin expression and function in the response of primary culture hepatic stellate cells to connective tissue growth factor (CCN2). J Cell Mol Med. 15:1087–1095. 2011. View Article : Google Scholar
38	Galicia-Moreno M, Rodríguez-Rivera A, Reyes-Gordillo K, et al: Trolox down-regulates transforming growth factor-beta and prevents experimental cirrhosis. Basic Clin Pharmacol Toxicol. 103:476–481. 2008. View Article : Google Scholar : PubMed/NCBI
39	Chen A: Acetaldehyde stimulates the activation of latent transforming growth factor-betal and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells. Biochem J. 368:683–693. 2002. View Article : Google Scholar : PubMed/NCBI
40	Sedlaczek N, Jia JD, Bauer M, et al: Proliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat bilinry fibrosis. Am J Pathol. 158:1239–1244. 2001. View Article : Google Scholar : PubMed/NCBI
41	Faouzi S, Le Bail B, Neaud V, et al: Myofibroblasts are responsible for collagen synthesis in the stroma of human hepatocellular carcinoma: an in vivo and in vitro study. J Hepatol. 30:275–284. 1999. View Article : Google Scholar : PubMed/NCBI
42	Friedman SL: Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem. 275:2247–2250. 2000. View Article : Google Scholar : PubMed/NCBI
43	Pinzani M and Marra F: Cytokine receptors and signaling in hepatic stellate cells. Semin Liver Dis. 21:397–416. 2001. View Article : Google Scholar : PubMed/NCBI